Mad in America

OCTOBER 24, 2024

A new commentary published in Current Opinion in Psychiatry presents the case for slow tapering of antipsychotics. According to authors Mark Horowitz and Joanna Moncrieff of University College London, slow tapering of antipsychotics can reduce the chance of relapse by allowing the brain time to adjust to the absence of these drugs. Stopping antipsychotic medication can be more dangerous than taking it, with withdrawal symptoms so severe they can feel like a return to the original illness –

83

83

Psychiatry News -- Science Daily

OCTOBER 24, 2024

Understanding animal emotions has been a long-running question at the forefront of welfare studies, but a new study may hold the key to decoding the chatter. The answer involves two baby chickens and a mirror.

52

52

Mad in America

OCTOBER 24, 2024

P eople who consider themselves suicide experts are usually just the opposite. They are biased towards drug use and cherry-pick the studies they quote even when they call their reviews systematic, [1] and suicide prevention strategies always seem to incorporate depression pills. [2] A 2015 “State of the Art review” in the BMJ claimed that “Evidence supports specific psychotropic drugs to reduce the risk of suicide.” [3] I explained why none of the references supported this. [4] There is no such

Aging and mental health 145

Aging and mental health Sleep and mental health Pharmaceuticals Insurance 145

Mad in America

OCTOBER 24, 2024

i went to the gym the other day and got hit on by a man over twice my age he asked me about my tattoos and where i went to school i was straddling the hip adduction machine wearing an art school t-shirt i explained how i didn’t go there anymore how i went there for music but i used to want to go for dance why did i feel the need to explain myself to this random stranger he made a joke about ballerinas and eating disorders and how i dodged a bullet on that one i wanted to spit my venom back at hi

Eating disorders 74

Eating disorders 74

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Healthcare